These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17906980)

  • 21. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
    Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
    J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on papillary microcarcinoma.
    Grodski S; Delbridge L
    Curr Opin Oncol; 2009 Jan; 21(1):1-4. PubMed ID: 19125011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
    Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
    J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
    Koperek O; Scheuba C; Puri C; Birner P; Haslinger C; Rettig W; Niederle B; Kaserer K; Garin Chesa P
    Int J Oncol; 2007 Jul; 31(1):59-67. PubMed ID: 17549405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma.
    Kim HY; Park WY; Lee KE; Park WS; Chung YS; Cho SJ; Youn YK
    J Cancer Res Ther; 2010; 6(4):452-7. PubMed ID: 21358079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proliferative activity of thyroid papillary microcarcinoma].
    Lantsov DS
    Arkh Patol; 2006; 68(5):16-9. PubMed ID: 17144524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic significance of selected oncogene and suppressor gene expression in follicular thyroid carcinoma].
    Lange D; Ferenc T; Niewiadomska H; Włoch J; Turska M; Burkacka J; Kula D; Lewiński A; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():72-8. PubMed ID: 12182065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
    Aoyagi S; Akiyama M; Shimizu H
    J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
    Sugitani I; Fujimoto Y; Yamamoto N
    Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
    Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
    Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.
    Lamba Saini M; Bouzin C; Weynand B; Marbaix E
    PLoS One; 2016; 11(2):e0148656. PubMed ID: 26863116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review.
    Nasir A; Chaudhry AZ; Gillespie J; Kaiser HE
    In Vivo; 2000; 14(2):367-76. PubMed ID: 10836212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterotopic intrathymic thyroid tissue.
    Hwang I; Lee SK; Cho KJ; Kim KR
    Pathol Int; 2006 Oct; 56(10):629-32. PubMed ID: 16984621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET proto-oncogene expression of papillary thyroid carcinomas in Thai patients.
    Keelawat S; Shuangshoti S; Assanasen T; Thanakit V; Ruangvejvorachai P; Poumsuk U; Wannakrairot P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S5-12. PubMed ID: 17718263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies.
    Inohara H; Segawa T; Miyauchi A; Yoshii T; Nakahara S; Raz A; Maeda M; Miyoshi E; Kinoshita N; Yoshida H; Furukawa M; Takenaka Y; Takamura Y; Ito Y; Taniguchi N
    Biochem Biophys Res Commun; 2008 Nov; 376(3):605-10. PubMed ID: 18809382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Yasuoka H; Kakudo K; Inohara H; Kuma K; Miyauchi A
    Pathology; 2005 Aug; 37(4):296-8. PubMed ID: 16194828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
    Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
    Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.